Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...

He has also proposed that the European Union create a common market for natural gas to offset the steep ... Today, she serves as senior director of employee relations at Vertex Pharmaceuticals, one of ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Florida International University has a new interim president, former state Lt. Gov. Jeanette Nunez. Even Stevens alum Christy ...

In India, many kids who work in retail markets have good math skills. They can quickly perform a range of calculations to complete transactions. But as a new study shows, these kids often perform ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...

Combinatorial optimization problems are challenging to solve due to their NP-hardness and the limitations of classical computing. This study introduces a surface acoustic wave-based Ising machine ...

Showcase your company news with guaranteed exposure both in print and online 25 years ago, Denver's economy thrived on IT, real estate & oil. DBJ will kick… Be Inspired! Meet Your Mentor! Make ...

University of Tennessee officials on Monday welcomed one of the most influential people in sports to campus to discuss the ...